The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology
Open accessAbstract
PURPOSE: Implementation of novel genetic diagnostic tests is generally driven by technological advances because they promise shorter turnaround times and/or higher diagnostic yields. Other aspects, including impact on clinical management or cost-effectiveness, are often not assessed in detail prior to implementation. METHODS: We studied the clinical utility of whole-exome sequencing (WES) in complex pediatric neurology in terms of diagnostic yield and costs. We analyzed 150 patients (and their parents) presenting with complex neurological disorders of suspected genetic origin. In a parallel study, all patients received both the standard diagnostic workup (e.g., cerebral imaging, muscle biopsies or lumbar punctures, and sequential gene-by-gene-based testing) and WES simultaneously. RESULTS: Our unique study design allowed direct comparison of diagnostic yield of both trajectories and provided insight into the economic implications of implementing WES in this diagnostic trajectory. We showed that WES identified significantly more conclusive diagnoses (29.3%) than the standard care pathway (7.3%) without incurring higher costs. Exploratory analysis of WES as a first-tier diagnostic test indicates that WES may even be cost-saving, depending on the extent of other tests being omitted. CONCLUSION: Our data support such a use of WES in pediatric neurology for disorders of presumed genetic origin.Genet Med advance online publication 23 March 2017.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., Braxton, A., Beuten, J., Xia, F., Niu, Z., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306555 · Cited by 1,964
Diagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
Self-citationThe economic cost of brain disorders in Europe
Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H. ‐., Jönsson, B., on behalf of the CDBE2010 study group, & the European Brain Council (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03590.x · Cited by 1,481
Molecular Findings Among Patients Referred for Clinical Whole-Exome Sequencing
Yang, Y., Muzny, D. M., Xia, F., Niu, Z., Person, R., Ding, Y., Ward, P., Braxton, A., Wang, M., Buhay, C., et al. (2014) · JAMA · doi:10.1001/jama.2014.14601 · Cited by 1,360
Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., Albrecht, B., Bartholdi, D., Beygo, J., Di Donato, N., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61480-9 · Cited by 1,041
Briggs, A. H., Wonderling, D. E., & Mooney, C. Z. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w · Cited by 882
Genetic studies in intellectual disability and related disorders
Vissers, L. E. L. M., Gilissen, C., & Veltman, J. A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg3999 · Cited by 761
Self-citationCoe, B. P., Witherspoon, K., Rosenfeld, J. A., van Bon, B. W. M., Vulto-van Silfhout, A. T., Bosco, P., Friend, K. L., Baker, C., Buono, S., Vissers, L. E. L. M., et al. (2014) · Nature Genetics · doi:10.1038/ng.3092 · Cited by 720
Self-citationAutosomal dominant cerebellar ataxias: polyglutamine expansions and beyond
Durr, A. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70183-6 · Cited by 656
Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units
Saunders, C. J., Miller, N. A., Soden, S. E., Dinwiddie, D. L., Noll, A., Alnadi, N. A., Andraws, N., Patterson, M. L., Krivohlavek, L. A., Fellis, J., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004041 · Cited by 656
Soden, S. E., Saunders, C. J., Willig, L. K., Farrow, E. G., Smith, L. D., Petrikin, J. E., LePichon, J.-B., Miller, N. A., Thiffault, I., Dinwiddie, D. L., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010076 · Cited by 528
Actionable, Pathogenic Incidental Findings in 1,000 Participants’ Exomes
Dorschner, M. O., Amendola, L. M., Turner, E. H., Robertson, P. D., Shirts, B. H., Gallego, C. J., Bennett, R. L., Jones, K. L., Tokita, M. J., Bennett, J. T., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.08.006 · Cited by 385
Neveling, K., Feenstra, I., Gilissen, C., Hoefsloot, L. H., Kamsteeg, E.-J., Mensenkamp, A. R., Rodenburg, R. J. T., Yntema, H. G., Spruijt, L., Vermeer, S., et al. (2013) · Human Mutation · doi:10.1002/humu.22450 · Cited by 331
Self-citationACMG Board of Directors (2014) · Genetics in Medicine · doi:10.1038/gim.2014.151 · Cited by 325
The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases
Gahl, W. A., Markello, T. C., Toro, C., Fajardo, K. F., Sincan, M., Gill, F., Carlson-Donohoe, H., Gropman, A., Pierson, T. M., Golas, G., et al. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e318232a005 · Cited by 291
Clinical whole exome sequencing in child neurology practice
Srivastava, S., Cohen, J. S., Vernon, H., Barañano, K., McClellan, R., Jamal, L., Naidu, S., & Fatemi, A. (2014) · Annals of Neurology · doi:10.1002/ana.24251 · Cited by 276
Unlocking Mendelian disease using exome sequencing
Gilissen, C., Hoischen, A., Brunner, H. G., & Veltman, J. A. (2011) · Genome Biology · doi:10.1186/gb-2011-12-9-228 · Cited by 266
Self-citationFORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project
Beaulieu, C. L., Majewski, J., Schwartzentruber, J., Samuels, M. E., Fernandez, B. A., Bernier, F. P., Brudno, M., Knoppers, B., Marcadier, J., Dyment, D., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.05.003 · Cited by 239
The usefulness of whole-exome sequencing in routine clinical practice
Iglesias, A., Anyane-Yeboa, K., Wynn, J., Wilson, A., Truitt Cho, M., Guzman, E., Sisson, R., Egan, C., & Chung, W. K. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.58 · Cited by 237
KDM6A Point Mutations Cause Kabuki Syndrome
Miyake, N., Mizuno, S., Okamoto, N., Ohashi, H., Shiina, M., Ogata, K., Tsurusaki, Y., Nakashima, M., Saitsu, H., Niikawa, N., et al. (2013) · Human Mutation · doi:10.1002/humu.22229 · Cited by 215
Pfundt, R., del Rosario, M., Vissers, L. E. L. M., Kwint, M. P., Janssen, I. M., de Leeuw, N., Yntema, H. G., Nelen, M. R., Lugtenberg, D., Kamsteeg, E.-J., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.163 · Cited by 183
Self-citationBredenoord, A. L., Onland‐Moret, N. C., & van Delden, J. J. M. (2011) · Human Mutation · doi:10.1002/humu.21518 · Cited by 150
Exome sequencing: a transformative technology
Singleton, A. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70196-x · Cited by 146
De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions
Mencacci, N. E., Kamsteeg, E.-J., Nakashima, K., R’Bibo, L., Lynch, D. S., Balint, B., Willemsen, M. A. A. P., Adams, M. E., Wiethoff, S., Suzuki, K., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.015 · Cited by 122
Self-citationUnderstanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases
Krabbenborg, L., Vissers, L. E. L. M., Schieving, J., Kleefstra, T., Kamsteeg, E.-J., Veltman, J. A., Willemsen, M. A. A. P., & van der Burg, S. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9958-5 · Cited by 121
Self-citationRegier, D. A., Peacock, S. J., Pataky, R. E., van der Hoek, K., Jarvik, G. P., Hoch, J. S., & Veenstra, D. L. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.140697 · Cited by 103
Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic
Lazaridis, K. N., Schahl, K. A., Cousin, M. A., Babovic‐Vuksanovic, D., Riegert‐Johnson, D. L., Gavrilova, R. H., McAllister, T. M., Lindor, N. M., Abraham, R. S., Ackerman, M. J., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.12.018 · Cited by 101
Towards a European consensus for reporting incidental findings during clinical NGS testing
Hehir‐Kwa, J. Y., Claustres, M., Hastings, R. J., van Ravenswaaij‐Arts, C. M. A., Christenhusz, G. M., Genuardi, M., Melegh, B., Cambon‐Thomsen, A., Patsalis, P. C., Vermeesch, J. R., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.111 · Cited by 100
An Incomplete Understanding of Human Genetic Variation
Huddleston, J., & Eichler, E. E. (2016) · Genetics · doi:10.1534/genetics.115.180539 · Cited by 90
Nolan, D. A., & Carlson, M. D. (2016) · Journal of Child Neurology · doi:10.1177/0883073815627880 · Cited by 74
The diagnostic pathway in complex paediatric neurology: A cost analysis
van Nimwegen, K. J. M., Schieving, J., Willemsen, M. A. A. P., Veltman, J. A., van der Burg, S., van der Wilt, G. J., & Grutters, J. P. C. (2014) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.12.014 · Cited by 49
Self-citationKrabbenborg, L., Schieving, J., Kleefstra, T., Vissers, L. E. L. M., Willemsen, M. A. A. P., Veltman, J. A., & van der Burg, S. (2015) · Clinical Genetics · doi:10.1111/cge.12601 · Cited by 27
Self-citationSie, A. S., Prins, J. B., van Zelst–Stams, W. A. G., Veltman, J. A., Feenstra, I., & Hoogerbrugge, N. (2014) · Clinical Genetics · doi:10.1111/cge.12433 · Cited by 25
Self-citationUse of Next-Generation Sequencing as a Diagnostic Tool for Congenital Myasthenic Syndrome
Das, A. S., Agamanolis, D. P., & Cohen, B. H. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.07.032 · Cited by 19
Cited by
Srivastava, S., Love-Nichols, J. A., Dies, K. A., Ledbetter, D. H., Martin, C. L., Chung, W. K., Firth, H. V., Frazier, T., Hansen, R. L., Prock, L., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0554-6 · Cited by 695
Self-citation100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report
The 100, 0. G. P. P. I. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035790 · Cited by 716
Clark, M. M., Stark, Z., Farnaes, L., Tan, T. Y., White, S. M., Dimmock, D., & Kingsmore, S. F. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0053-8 · Cited by 619
Manickam, K., McClain, M. R., Demmer, L. A., Biswas, S., Kearney, H. M., Malinowski, J., Massingham, L. J., Miller, D., Yu, T. W., & Hisama, F. M. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01242-6 · Cited by 639
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
Metadata
- Authors
- Vissers, L. E. L. M., van Nimwegen, K. J. M., Schieving, J. H., Kamsteeg, E.-J., Kleefstra, T., Yntema, H. G., Pfundt, R., van der Wilt, G. J., Krabbenborg, L., Brunner, H. G., van der Burg, S., Grutters, J., Veltman, J. A., & Willemsen, M. A. A. P.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 19
- Issue
- 9
- Pages
- 1055-1063
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2602589905
- Cited by
- 270
- References
- 36
- FWCI
- 17.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.